Clinical profile of dilated cardiomyopathy in children enrolled in chronic cardiac care: a decade review in a sub-Saharan African tertiary center Authors: Henock Gashaw, Henok Tadele Published: 2024 ABSTRACT AbstractBackgroundDilated cardiomyopathy (DCM) is a myocardial disease characterized by a dilated left ventricle (LV) and reduced LV systolic function. The clinical profile of DCM is not well studied in Africa with no reports from Ethiopia. This study aimed to describe the clinical profile of DCM and the factors associated with its clinical outcome in a tertiary center.ResultsThis study included 75 DCM patients, males 52%. The median age at DCM diagnosis was 18 months (Interquartile range/IQR: 7–46). The major DCM clinical presentations were cough, 84%, fast breathing, 64% and shortness of breath, 56%. The median left ventricular systolic ejection fraction (LVEF) and left ventricular fractional shortening (LVFS) at diagnosis were 30% (IQR: 24–36) and 14% (IQR: 11–18), respectively. The majority don’t have a cause labeled or documented, 81.3% while HIV and anthracycline-related DCM accounted for 6.7% each. Concerning outcomes, the majority didn’t show any clinical status change or were static, 62.7% while one-third, 32%, showed improvement. The case fatality rate in this series was 5.3% [4] (95% CI: 1.47–13.1). The presence of severe acute malnutrition (wasting) at presentation, p 0.017; the latest LV systolic function (LVEF, p 0.000 and LVFS, p 0.000) and the use of enalapril, p 0.017, were associated with DCM clinical outcome.ConclusionBoys in their second birth year were most affected by DCM. The major DCM presentations were a mix of respiratory and cardiac symptoms with severely depressed LV systolic function. Nutritional status at presentation, recent LV systolic function and enalapril use were associated with DCM clinical outcome. Timely nutritional assessment, treatment and support, and enhanced HF medical treatment are recommended to improve DCM clinical outcomes.Keywords: Dilated cardiomyopathy, Cardiomyopathy, Children, HIV, Outcome, Ethiopia, Africa Background Dilated cardiomyopathy (DCM) is a myocardial disease characterized by a dilated left ventricle (LV) and reduced systolic function. DCM is the most common childhood cardiomyopathy and the cardiac dilation is not explainable by loading conditions or coronary artery disease [1–3]. Studies from developed settings estimated a DCM yearly incidence of 0.57 cases per 100,000 children less than 18 years of age. It affects black infant boys [4]. Asian studies also documented a due burden of DCM with slight male dominance [5, 6]. A Sudanese study estimated a yearly DCM incidence of 1.4 cases per 100,000 children younger than 18 years with more occurrences in females [7]. DCM could be primary or secondary depending on an underlying cause. The primary DCM includes familial or genetic DCM while the secondary includes inflammatory, toxins/drugs, metabolic and nutritional causes [8]. From inflammatory causes, infectious causes commonly viruses like HIV, adenoviruses, and enter viruses, are listed [8, 9]. DCM has often no known cause or is idiopathic, 45–66% while myocarditis and neuromuscular diseases constitute 46–49% and 26%, respectively [4, 7]. The clinical presentation of DCM includes shortness of breath, failure to thrive, edema, pallor and cool extremities [1, 6, 7]. Diagnosis of DCM requires a thorough history, physical examination, Chest X-ray (CXR) and echocardiographic assessment. Echocardiography is an initial and guiding diagnostic tool for DCM in children. Targeted blood workup, endomyocardial biopsy and Cardiac Magnetic Resonance imaging (CMR) may be considered to guide the subsequent care of the child with DCM [1, 8]. The medical treatment aims to control symptoms and stop disease progression. Medical management of DCM depends on the stage of DCM with those presenting with Heart Failure (HF) symptoms initiated on diuretics, Angiotensin-Converting Enzyme Inhibitors (ACEI) and beta-blockers. Inotropic agents are indicated when hypotension accompanies the patient’s presentation. Heart transplantation is indicated for advanced cases [1, 10]. The prognosis of childhood DCM is recovery, with no change or death [1, 7, 8, 10]. Age at DCM diagnosis of over 3 years was associated with death [4, 5, 11] while an infantile diagnosis was associated with death in other studies [6, 11]. Heart failure at DCM diagnosis and idiopathic DCM form also predicted death [4]. The most common cause of DCM death was heart failure or arrhythmia [1]. Functional HF class IV, arrhythmia, low left ventricular systolic ejection fraction at presentation, and cardiomegaly on CXR predicated death among children with DCM in another study [12]. Females had increased mortality though cardiac transplantation improved survival [11]. On the contrary, children with DCM showed improved survival recently without transplantation [13]. The clinical profile of childhood DCM and factors associated with its clinical outcome is an understudied subject with limited reports from developed countries and a handful from Africa with none from Ethiopia. This study aimed to determine the clinical profile and factors associated with the clinical outcome of DCM in children enrolled in chronic cardiac care at the National Cardiac Referral Hospital of Ethiopia. Methods Study design and study period A cross-sectional study on patient medical records included periods from Nov 2013 to Dec 2023. Data were collected between November and December 2023. Study area The study was conducted in Tikur Anbessa Specialized Hospital (TASH) at the cardiac follow-up clinic of the Department of Pediatrics and Child Health. The cardiac clinic runs all five working days of the week and is attended by trained nurses, pediatric residents, pediatric cardiology fellows, and pediatric cardiologists. The clinic serves all patients who come from all Ethiopian regions. The hospital has dedicated and well-equipped intensive care units (general pediatric and a separate cardiac intensive care), a pediatric echocardiography laboratory, and other imaging like CXR, computed tomography and magnetic resonance imaging. TASH is the national cardiac referral hospital of Ethiopia and is owned by Addis Ababa University. Study population All children aged 10 months to 18 years and diagnosed with dilated cardiomyopathy and enrolled in follow-up at the TASH cardiac clinic. Sample size and inclusion criteria As DCM is a disease with regional and global incidence rates of 0.06–0.14% [7], medical records of all children with DCM who fulfilled the inclusion criteria were included in the study. Finally, 75 children between the ages of 10 months and 18 years, with a diagnosis of DCM and enrolled in chronic cardiac care were included in the study. Data collection Data were collected from the medical records of DCM patients using a questionnaire prepared for this study. Variables The dependent variable was the current clinical status of a DCM patient, improved, static or dead. Age, sex, residence, region of residence in Ethiopia, age at diagnosis, nutritional status, LV ejection fraction and fractional shortening at presentation, co-morbidity, duration of treatment or follow-up, recent LVEF and recent LVFS, the use of medications (Lasix, aspirin, captopril, Spironolactone, carvedilol, digoxin and enalapril) were the independent variables. Operational definitions LV systolic function was considered severely and mildly reduced when the ejection fraction was ≤ 30% and between 41 and 55%, respectively [14, 15]. LV systolic function was considered normal and severely reduced when the LV fractional shortening was 26–45% and ≤ 14%, respectively [15, 16]. Nutritional status was assessed and grouped as normal, malnourished, stunted or underweight based on World Health Organization curves and guidelines [17, 18]. The clinical outcome was a patient status: improved, dead or static. Data analysis Analysis was done on Statistical Software for Social Sciences Version 25. A median with an Interquartile range was used to report continuous variables. A chi-square or Fisher’s exact test was done to check the association between the dependent and independent variables. Statistical significance was set at p < 0.05. Results Socio-demographic data of the study participants This study included 75 children with the diagnosis of DCM who were enrolled in chronic cardiac care. Boys constituted 52% (39) of the case series. The majority were residents of Addis Ababa, 52% (39) while the rest, 48% (36), were from other Ethiopian regional states. The median age of the study participants was 74 months (IQR: 48–144); the youngest was 10 months old. The median age at diagnosis of DCM was 18 months (IQR: 7–46); the youngest was 2 months old. Regarding anthropometry, 36% [27] of children with DCM were malnourished, and 20% [15] were severely malnourished (see Table 1). Table 1Socio-demographic and anthropometric data of children with dilated cardiomyopathy at Tikur Anbessa Specialized HospitalVariableCategoryProportion(n)Percentage (%)Age(months)≤ 60273660.1-119.92128≥ 1202736GenderMale3952Female3648Age at diagnosis (months)≤ 122938.712.1–35.92229.3≥ 362432Region of residence, EthiopiaAddis Ababa3952Oromia2229.3Amhara810.7SNNPR*45.3Others22.7AnthropometryWeight for heightNormal4864Malnourished2736Height for ageNormal6485.3Stunted1114.7Weight for ageNormal5674.7Under weight1925.3*Southern Nations, Nationalities and Peoples Regional state, now divided into different regional states Socio-demographic and anthropometric data of children with dilated cardiomyopathy at Tikur Anbessa Specialized Hospital *Southern Nations, Nationalities and Peoples Regional state, now divided into different regional states Clinical profile of children with dilated cardiomyopathy The major clinical presentations of the study participants were cough, 63(84%), fast breathing, 48(64%) and shortness of breath, 42(56%). The median left ventricular systolic ejection fraction and fractional shortening at diagnosis were 30% (IQR: 24–36) and 14% (IQR: 11–18), respectively. The lowest LV ejection fraction was 10% while the lowest LV fractional shortening was 6%. Only half of the study participants had their LV chamber size documented on the medical records, 49.3% (37). Based on the recorded values, the median LV size was 4.2 cm (IQR: 3.8–4.9) (see Table 2). Table 2Clinical characteristics of children with dilated cardiomyopathy at Tikur Anbessa Specialized HospitalVariableCategoryProportion(n)Percentage (%)Clinical presentation+Cough6384Fast breathing4864Shortness of breath4256Irritability2938.7Edema2229.3Sweating1824Orthopnea810.7Palpitation56.6Syncope11.3Echocardiographic LV functions (at diagnosis)EF (%)≤ 29.93749.3≥ 303850.7FS (%)≤ 144357.3> 14.13242.7TreatmentFurosemide7498.7Digoxin7090.3Aspirin5573.3Captopril3850.7Enalapril2736Spironolactone810.7Carvedilol45.3Co-morbid conditionYes3952No3648Duration of treatment or follow up< 5 years4965.3≥ 5 years2634.7+a single patient could have one or more of those presentation symptoms Clinical characteristics of children with dilated cardiomyopathy at Tikur Anbessa Specialized Hospital +a single patient could have one or more of those presentation symptoms In this study population, the most commonly identified etiologies for DCM were HIV-related, 6.7% [5], drug-related 6.7% [5], chronic kidney disease/CKD-related hypertension 5.3% [4] while the majority didn’t have a cause labeled, 81.3% (61). The offending drug was doxorubicin which was used for patients with Ewing sarcoma [1] and Wilms tumor [4]. The median exposure dose of doxorubicin was 300 mg/m2 (IQR: 225–325). Duchene muscular dystrophy-related DCM was documented in a 12-year-old. None of the study subjects had cardiac MRI or endomyocardial biopsy. The major DCM clinical complications were heart failure, 53.35(40), cardiac thrombus at 8% [6], and arrhythmia at 4% [3] (see Table 2). Treatment and outcome Almost all of the children with DCM were on lasix, 98.7% (74) and digoxin, 93.3% (70). A different class of drug combinations that included aspirin, captopril, spironolactone, carvedilol, and enalapril were used during treatment. The majority of DCM subjects received medical treatment or follow-up for 1–5 years, 65.3% (49). None of our study subjects had heart transplantation. The median latest LVEF and LVFS were 41% (IQR: 28–55) and 20% (IQR: 13–28), respectively. Concerning outcome or current status, the majority didn’t show any clinical status change or were static, 47 (62.7%), while one-third, 32% [24] showed improvement. The case fatality rate in this series was 5.3% [4] (95% CI: 1.47–13.1) (See Table 2). Factors associated with treatment outcome The presence of severe acute malnutrition (wasting) at presentation, p 0.017; the latest LV systolic function (LVEF, p 0.000 and LVFS, p 0.000) and the use of enalapril, p 0.017, were associated with DCM clinical improvement (see Table 3). Table 3Factors associated with outcome among children with dilated cardiomyopathy in TASHVariableCategoryDisease outcomeCOR [95% CI]p ValueImprovedStatic /diedAge (months)Less or equal to 605220.3470.112–1.070.0661 and above19291GenderMale10290.5420.203–1.4480.219Female14221Age at diagnosis (months)≤ 129200.9300.342–2.5270.88713 and above15311RegionAddis Ababa12270.8890.337–2.3470.812Others12241Weight for heightNormal20284.1071.229–13.731 0.017 Malnourished423Height for ageNormal22422.3570.468–11.8710.288Stunted29Weight for ageNormal15410.4070.138–1.1940.097Underweight910Presentation LVEF≤ 3014271.2440.467–3.3170.662> 301024Presentation LVFS≤ 1413300.9300.342–2.5270.887> 141121Comorbid diseaseYes13211.6880.635–4.4880.292No1130Duration of treatment< 5 years13360.4920.180–1.3440.163≥ 5 years1115LVFS recent (%)26–4520125026.3-2376.27 0.000 ≤ 25450LVEF recent (%)≥ 5022317627.43-1129.42 0.000 < 50248LasixYes24500.676 0.577–0.7911.000No01AspirinYes17380.831 0.282–2.4520.737No713CaptoprilYes16222.636 0.957–7.6240.057No829SpironolactoneYes442.35 0.534–10.3380.259No2047CarvedilolYes041.511 1.279–1.7840.299No2447DigoxinYes21490.286 0.044–1.8370.319No32EnalaprilYes4230.243 0.073–0.814 0.017 No2028 Factors associated with outcome among children with dilated cardiomyopathy in TASH Discussion In this case series, children with DCM were males in their second birth year during DCM diagnosis. The main DCM presentation symptoms were cough, fast breathing and shortness of breath. The majority had severely depressed LV systolic function at presentation. Except for a few cases of HIV and doxorubicin-related DCM, the majority didn’t have a cause identified or documented. A third of DCM showed improvement while the case fatality was 5%. Nutritional status, enalapril use and recent LV systolic function were associated with DCM clinical outcome. In this study, the median age at DCM diagnosis was 1.5 years. Comparable results were reported in other retrospective studies [5, 19–21]. This is as opposed to an older age in other studies [7, 22]. The difference in the setup and study design (prospective in the Sudanese report) may be considered for the noted contradiction. DCM was relatively common among boys in this study. This is in agreement with other studies [4–6, 20, 23]. Female dominance was reported in a Sudanese study [7]. However, the duration of the study in the latter was short. In the current study, the main DCM clinical presentations were cough, fast breathing and shortness of breath. Similar clinical presentations were documented in related studies [6, 7, 21, 22]. These symptoms are usually due to heart failure, a final pathway for DCM patients [1]. Moreover, the majority of DCM patients had severely depressed LV systolic function at presentation in this study. This is also similar to other studies [7, 22] and goes hand-in-hand with the clinical presentations of the study subjects in this study. Nutritionally, the majority didn’t have any malnutrition in the current study. This is opposed to malnutrition in half of childhood DCM in another study [7] and high malnutrition in Ethiopian children [24]. This finding points to the acute DCM presentation among the study participants of the current study. Concerning etiologies for DCM, the majority didn’t have a cause identified or documented. This speaks for the definitive DCM diagnostic challenges in the study and related facilities. From the documented causes, HIV and Doxorubicin-related DCM were common. The figure of HIV-associated dilated cardiomyopathy in our study is lower than other reports from Africa which documented a high occurrence of DCM in African HIV patients: Rwanda, 18%; Nigeria, 33.7%; Cameroon, 23% [25–27]. Given the high HIV burden in children with limited timely diagnosis and treatment for HIV prevention and control [28, 29], the finding is only provisional calling for more detailed studies on the burden of DCM among HIV-infected Ethiopian children. Moreover, the finding of anthracyclines-associated DCM begs for timely attention and adherence to the oncologic treatment protocols and screening follow-up recommendations [8]. The case fatality in this series is lower than in other related studies [6, 7] but similar to another study [21]. In this study, the rate of recovery was comparable with other studies [6, 7]. However, it is lower than another report [21]. Differences in the etiologies and treatment capabilities of the study settings can be postulated reasons. It should also be noted here that in the current study, a specific etiology was not identified or documented and hence association with prognosis could not be made. In this study, severe acute malnutrition or wasting was associated with DCM clinical outcomes. It is a fact that malnutrition is in the background of most childhood deaths in developing countries [30]. The demand for energy increases putting these children with DCM in negative energy balance and emaciation as symptoms of heart failure evolve. Timely nutritional assessment, treatment and support could prevent the mortality seen in children with DCM. Moreover, the use of enalapril and the latest LV systolic function were associated with DCM clinical outcomes in this study. This could be related to the optimal heart failure treatment in this case series with the use of different classes of medications as HF is associated with increased mortality [4]. The noted association between enalapril and DCM clinical outcome could be related to the lack of an expected dose-dependent response among Ethiopian children where these children are currently put on crushed adult tablets limiting the exact dose response due to a lack of a syrup or pediatric formulation in Ethiopia. Moreover, this finding calls for more large-scale prospective studies with good clinical and echocardiographic data to further validate this in Ethiopian DCM patients. This study has limitations which include single-centeredness, lack of definitive etiologic diagnosis (genetic, nutritional tests, cardiac biopsy or cardiac MRI), lack of inclusion of severe DCM patients who could have died locally or in hospital admission, sample size and incomplete information on some variables limiting multivariable analyses. However, a review of a decade of data from the National Cardiac Referral Center on the case of DCM with the identification of factors that are associated with morality is the strength of this study. Additionally, the findings will help DCM-treating physicians in this and related resource-poor settings to focus on the assessment and treatment of nutritional problems, and optimization of HF treatment to avert mortality. The study will also serve as baseline data that fosters regional and international collaboration for the future development of the DCM or cardiomyopathy database. Conclusion Most Ethiopian children with DCM were males in their second birth year during diagnosis. Most DCM patients presented with a mix of respiratory and cardiac symptoms with severely reduced LV systolic function. The majority don’t have a cause identified or documented. One-third had recovered while the majority was static with no status change. Nutritional status at presentation, enalapril use and recent LV systolic function were associated with DCM clinical outcome. Timely nutritional assessment, treatment and support, and enhanced HF medical treatment are recommended to prevent DCM mortality. Acknowledgements We thank the Department of Pediatrics and Child Health for facilitation of the study. Abbreviations Chest X-ray Chronic kidney disease Dilated cardiomyopathy Ejection fraction Fractional shortening Heart failure Human immunodeficiency virus Interquartile range Left ventricle Odds ratio South Nations and Nationalities Regional state Tikur Anbessa Specialized Hospital Author contributions HG wrote the draft proposal, designed data collection tool, supervised data collection process and analyzed the data, wrote the draft manuscript. HT conceived the idea, supervised the proposal development process, data analysis and write up. HT wrote the manuscript in its current form. All authors read and approved the manuscript. Funding Funding was obtained from the school of Graduate Studies of Addis Ababa University. The funder didn’t have any role in the design, data collection, analysis and write up of the study. Data availability The datasets analyzed during this study are available from the corresponding author up on reasonable request. Declarations Ethical approval and consent to participate Waiver of consent and ethical approval was obtained from the Research Ethics Committee of the Department of Pediatrics and Child Health, College of Health Sciences, Addis Ababa University with minute number 007/15. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets analyzed during this study are available from the corresponding author up on reasonable request.